The problem of the healthcare archipelago can very easily be demonstrated by considering a few questions.

In an ideal world, these would be easy to answer. Given the current organisation of healthcare, they are not – they are “killer questions”. These types of enquiries can be applied to healthcare organisations of any size and in any country. Do you understand the variation in healthcare outcomes and value across parts of your healthcare service? If not, Better Value Healthcare can help.

In the UK, we will not have a truly National Health Service (NHS) until we can answer questions such as these:

  • Is the service for people with seizures & epilepsy in Manchester of higher value than the service in Liverpool?
  • How many liver disease services are there in England and how many should there be?
  • Which service for people at the end of life in London provides the best value?
  • Is the service for people with asthma in Devon of higher value than the service in Somerset?
  • How many services are there for people with MusculoSkeletal Disease in the North East, and which gives best value?

England is not alone; no country can presently answer questions such as:

  • Is the service for people with seizures and epilepsy  in Madrid better than the one in Toronto?
  • How many liver disease services are there in each Erewhon partner and how many should there be?
  • Which service for frail elderly people in London, Sydney, Paris, Berlin and Madrid provides the best value?
  • Do women with pelvic pain get better value care in Paris or Madrid or Berlin?
  • Do people with asthma getter better value care in Madrid or Paris or London?
  • How many services are there for people with MusculoSkeletal Disease in Madrid, London, Paris  and Toronto, and which gives best value?